CANF | Can-Fite BioPharma Ltd.
Category: Company
Quick infos Trade prices Volume: Market Cap: 32.15M Prev closed: 2.33 Open: 2.49 High: 2.8 Low: 2.36 52 week low: 1.08 52 week high: 4.95 Dividends: No Dividends Next ER: September 9, 2021 Before Market Opens
Company Profile Can-Fite BioPharma (TASE:CFBI; NYSE MKT:CANF) is an Israeli biopharmaceutical company with fully integrated pharmaceutical discovery and clinical development capabilities.
Earnings History Date EPS / Forecast Revenue / Forecast December 1, 2021 August 26, 2021 -0.12 / -0.05250K / 218.33KBeat! May 27, 2021 - / -0.135148K / 300KMarch 25, 2021 -0.24 / -0.135175K / 500KNovember 30, 2020 -0.15 / -0.235211K / 211Kview more
Historical Data Date Price Open High Low Vol Change ER Sep 9, 2021 1.780 1.790 1.790
1.760
91.08K 0.56% Sep 8, 2021 1.770 1.800 1.840
1.750
95.69K -2.21% Sep 7, 2021 1.810 1.830 1.900
1.780
90.87K -2.16% Sep 3, 2021 1.850 1.780 1.930
1.760
325.62K 3.35% Sep 2, 2021 1.790 1.890 1.890
1.710
575.00K -2.98% Sep 1, 2021 1.845 1.850 1.865
1.840
83.35K -0.81% Aug 31, 2021 1.860 1.840 1.880
1.840
48.09K 0.54% Aug 30, 2021 1.850 1.890 1.910
1.810
242.76K -1.33% Aug 27, 2021 1.875 1.870 1.930
1.860
138.91K 0.27% Aug 26, 2021 1.870 1.830 1.890
1.830
72.18K 1.08% view more
NYSEAMERICAN
More profiles and info about the company News
Can-Fite Abstract Selected For Liver Conference finance.yahoo.com Sep 30, 2020 11:52 am
Benzinga Pro's Top 5 Stocks To Watch For Fri., Mar. 13, 2020: GLD, OPK, IBIO, CPB, CANF finance.yahoo.com Sep 30, 2020 8:13 am
Can-Fite: New Pre-clinical Studies Demonstrate Inhibition of Fat Cell Expansion by Cannabis Derived CBD finance.yahoo.com Sep 30, 2020 7:30 am Can-Fite Shares Surge on Univo Accord to Develop Cannabis-Based Therapeutics thestreet.com Sep 30, 2020 5:38 am Can-Fite Surges on Study Hopes for Arthritis Drug in Coronavirus Treatment thestreet.com Aug 28, 2020 7:54 am Can-Fite Biopharma EPS beats by $0.32, misses on revenue seekingalpha.com Aug 27, 2020 7:08 pm Can-Fite BioPharma poised to nab European patent for Namodenoson seekingalpha.com Aug 25, 2020 8:55 pm Seeking Alpha Catalyst Watch seekingalpha.com Aug 22, 2020 2:56 am
Can-Fite to Explore the anti-Coronavirus Effects of Piclidenoson in Collaboration with Lewis Katz School of Medicine at Temple University finance.yahoo.com Sep 30, 2020 7:00 am
FDA Clears Can-Fite to Commence Phase II COVID-19 Study finance.yahoo.com Sep 30, 2020 7:00 am
Can-Fite Selected to Deliver Late-Breaking Oral Presentation on Namodenosons Treatment of NASH at American Association for the Study of Liver Diseases Conference finance.yahoo.com Sep 30, 2020 7:00 am
Can Fite Received Approval for COVID-19 Clinical Trial in Israel, Patient Enrollment and Dosing to Commence Immediately finance.yahoo.com Sep 30, 2020 6:30 am
Can-Fite to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 14, 2020 finance.yahoo.com Sep 8, 2020 7:00 am
Can-Fites Phase II Liver Cancer Data Selected for Presentation at a Leading Liver Cancer Scientific Forum (ILCA) finance.yahoo.com Aug 28, 2020 7:00 am
Can-Fite Granted U.S. Patent for Piclidenoson in the Treatment of Osteoarthritis, Positioning this Indication for Animal Health Market finance.yahoo.com Aug 28, 2020 7:00 am
Can-Fite Reports Third Quarter 2019 Financial Results & Provides Clinical Update finance.yahoo.com Aug 28, 2020 7:00 am
Can-Fite CEO Issues Letter to Shareholders finance.yahoo.com Aug 28, 2020 7:00 am
Can-Fite Updates on Clinical Milestone for its Phase III Rheumatoid Arthritis Study with Piclidenoson; Drugs Combating Rheumatoid Arthritis are Currently Introduced for the Treatment of the Coronavirus finance.yahoo.com Aug 28, 2020 7:00 am
Can-Fite BioPharma Ltd. to Host Earnings Call finance.yahoo.com Aug 28, 2020 6:30 am
Can-Fite Enters into Strategic Agreement with Univo Pharmaceuticals to Develop Cannabinoid-Based Pharmaceuticals and Assays finance.yahoo.com Aug 28, 2020 6:03 am This company doesn't provide a dividend.
Talk about Can-Fite BioPharma Ltd. below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.
A simple, straightforward guide to the fundamentals of technical analysis
